Brenipatide (LY3537031) is a dual GIP/GLP-1 agonist from Eli Lilly designed for monthly administration. Scientific guide: mechanism, phase 3 addiction trials (alcohol), and comparison with tirzepatide and retatrutide.
Cagrilintide (AM833) is a long-acting amylin analogue being studied for satiety and weight loss, alone and in combination with semaglutide (CagriSema). This scientific guide outlines its mechanisms of action and specifications.
The Wolverine Stack combines BPC-157 and TB-500, the two most studied tissue repair peptides. This scientific guide details its composition, synergistic mechanisms, and technical specifications.
KLOW is a research blend combining four repair peptides in a single vial: GHK-Cu, BPC-157, TB-500, and KPV. This scientific guide details its composition, multi-pathway mechanisms, and technical specifications.
Retatrutide (LY3437943) is the first triple GLP-1/GIP/glucagon agonist approached in a phase 3 clinical trial. With a reduction in body weight reaching 24% in phase 2 studies, it surpasses in efficacy all molecules known to date in obesity research.
COMPARATIVE GUIDE Research on GLP-1 peptides has evolved rapidly in recent years: from the monoagonist Semaglutide
Peptide Guide 12 min read Ipamorelin: The Selective GH Secretagogue — Complete Scientific Guide Third-stage Synthetic Pentapeptide
Peptide Guide 12 min read Semax: Nootropic and Neuroprotective Peptide — Complete Scientific Guide Synthetic Analogue of the fragment
Peptide Guide 12 min read Selank: the nootropic anxiolytic peptide — Complete scientific guide Developed by the Institute of
Peptide guide, 13-minute read: PT-141 (Bremelanotide): mechanisms, research, and complete pharmacological profile. A synthetic derivative of α-MSH, the
